00:00:00
December 4th, 2024.
00:00:02
Midtown Manhattan.
00:00:04
Early in the morning, Brian Thompson,
00:00:06
the CEO of United Health
00:00:08
Care, is gunned down.
00:00:09
Inscribed into the bullets.
00:00:11
Deny, depose and defend.
00:00:14
A reference to the tactics
00:00:16
used by health care companies
00:00:17
to increase profits. To the media’s
00:00:19
surprise
00:00:20
Americans show little empathy
00:00:22
towards the victim,
00:00:23
and instead, a country wide
00:00:25
discussion begins
00:00:26
on the state of universal health care.
00:00:28
Today, Americans spend more on health
00:00:31
care than every country on Earth
00:00:33
and by a wide margin.
00:00:35
Worse yet,
00:00:36
Americans spend more
00:00:37
even though they see a doctor 50% less
00:00:41
than other wealthy nations
00:00:43
and the cherry on top?
00:00:44
The average US life
00:00:46
expectancy is three years
00:00:47
lower than comparable countries.
00:00:49
What went wrong?
00:00:51
This is US health care,
00:00:53
an American sickness.
00:00:56
The US
00:00:57
spends nearly $5
00:00:58
trillion on health care every year.
00:01:00
This represents almost 18% of GDP.
00:01:04
However, for all of this money,
00:01:06
the US gets very little.
00:01:08
And ranks
00:01:08
last among ten high income countries
00:01:11
for health outcomes and access.
00:01:13
Even when looking at it
00:01:14
from a purely financial point of view.
00:01:17
Improving the US health care system
00:01:19
could save Americans
00:01:20
nearly $2.5 trillion.
00:01:24
That's enough
00:01:24
to exceed the mandate of Doge
00:01:26
in one year.
00:01:28
To understand
00:01:29
what's driving these high costs
00:01:30
and poor outcomes,
00:01:31
we need to break out
00:01:32
the different components
00:01:34
of the US health care system.
00:01:35
Insurance, health care providers
00:01:38
and pharma.
00:01:39
Let's start off
00:01:40
with health care insurance.
00:01:43
92% of all Americans
00:01:45
have some form of health insurance.
00:01:47
Generally, it's
00:01:48
broken down into employer
00:01:50
sponsored programs.
00:01:51
Government programs,
00:01:52
and individual plans.
00:01:54
Unlike most of the developed world,
00:01:56
when Americans have insurance,
00:01:58
they can select
00:01:58
from multiple providers.
00:02:00
This introduces choice,
00:02:01
which some argue is nice
00:02:03
and allows the consumer
00:02:05
to decide what's best for them.
00:02:07
However, it also introduces complexity.
00:02:10
Each insurance payer can have different
00:02:12
billing codes,
00:02:13
payment processes,
00:02:15
prior authorization protocols,
00:02:17
service levels,
00:02:18
doctor networks,
00:02:19
pharmacy networks, PBMs, and more.
00:02:22
The outcome
00:02:23
providing care becomes
00:02:25
a lot less about medicine
00:02:27
and much more about
00:02:28
administrative functions.
00:02:30
According to the AHA, 40% of total expenses
00:02:34
incurred by hospitals
00:02:35
are related
00:02:36
to administrative functions.
00:02:38
Not medicine. Not care.
00:02:40
Not surgery.
00:02:41
No admin.
00:02:43
In fact, when you compare the U.S.
00:02:45
with other developed
00:02:45
nations, 30% of the difference in cost
00:02:49
is directly due
00:02:50
to administrative overhead
00:02:52
introduced by the insurance regime.
00:02:55
But money isn't everything.
00:02:56
To truly understand the impact.
00:02:58
We need to look at patient outcomes.
00:03:01
U.S.
00:03:01
health insurance
00:03:02
companies deny 16% of all claims,
00:03:06
with companies
00:03:06
like UnitedHealthCare and Medica
00:03:08
denying 32 and 27%, respectively.
00:03:12
This means that a doctor
00:03:13
seeking to provide care
00:03:14
is being rejected
00:03:15
by an insurance company.
00:03:17
nearly one out of every five times.
00:03:20
Ultimately,
00:03:21
this leads to patients
00:03:22
having to make tough decisions
00:03:24
of paying out of pocket
00:03:25
or not pursuing care at all.
00:03:28
For those paying out of pocket,
00:03:29
it could mean taking on large
00:03:31
sums of debt,
00:03:32
often with costs so high that 67%
00:03:35
of all US bankruptcies
00:03:37
are healthcare related,
00:03:39
or they can join the nearly 40%
00:03:42
of Americans
00:03:42
who have or know a family member
00:03:45
who has delayed medical care
00:03:46
due to cost,
00:03:48
often paying the ultimate price.
00:03:50
Health insurance
00:03:51
companies argue
00:03:52
that they do this
00:03:53
to control costs for patients
00:03:55
and ensure that hospitals
00:03:56
aren't being overzealous,
00:03:58
which is partially true.
00:04:00
But these insurance companies
00:04:02
are increasing
00:04:03
the rate of denials over time
00:04:05
and employing new technologies
00:04:07
to quickly reject claims.
00:04:09
From 2022 to 2023,
00:04:11
care denials increased 20 and 56%
00:04:15
for commercial
00:04:16
and Medicare Advantage
00:04:17
claims, respectively.
00:04:19
They do this
00:04:19
because less than 1% of
00:04:21
all claims are appealed.
00:04:23
This isn't because patients
00:04:24
don't believe they need care,
00:04:26
but appealing is costly.
00:04:28
complicated and very time consuming.
00:04:31
Remember, deny, depose and defend.
00:04:34
To make matters worse, 75%
00:04:37
of all Medicare Advantage
00:04:39
denials were overturned.
00:04:41
That's 216,000 denials.
00:04:45
The misalignment of incentives
00:04:47
is so clear and abundant
00:04:49
that it is shocking
00:04:51
that this continues.
00:04:52
It is absolutely in the insurance
00:04:54
company's best interest
00:04:56
to deny as often as legally possible,
00:04:59
regardless of the claim.
00:05:01
But let's not forget
00:05:03
this isn't a rejection
00:05:04
of auto insurance.
00:05:06
This is possibly preventing a human
00:05:08
being in their most vulnerable state
00:05:10
from receiving care that they need.
00:05:13
But if we dig deeper,
00:05:14
it continues to get worse.
00:05:17
Prior
00:05:17
authorizations are a form of approval
00:05:19
that insurance companies must provide
00:05:21
for certain types of care.
00:05:23
This means that if a doctor requires
00:05:25
a certain type of care
00:05:26
for their patient
00:05:27
before they can proceed,
00:05:29
they must get approval
00:05:30
from the insurance company.
00:05:31
Again,
00:05:32
insurance payers claim
00:05:34
that this is to ensure
00:05:35
that care being provided
00:05:37
is actually needed, but often it leads
00:05:40
to extremely negative consequences.
00:05:42
For instance,
00:05:43
30% of radiation oncologists
00:05:46
have had a patient
00:05:47
admitted into the emergency room
00:05:49
or have permanent disability
00:05:52
due to prior authorizations.
00:05:54
This means that a patient was prevented
00:05:56
from getting care in a timely manner
00:05:59
because of the administrative burden
00:06:01
of prior authorizations,
00:06:02
and the outcome was life changing
00:06:05
to receive authorization.
00:06:07
These oncologists need to draft
00:06:09
an explanation
00:06:10
for the insurance companies
00:06:11
that is reviewed by a doctor,
00:06:13
referred to as a peer.
00:06:15
However, 35%
00:06:17
of these peers aren't oncologists,
00:06:21
but this isn't solely an issue
00:06:23
for oncology.
00:06:24
Across all specialties, doctors claim
00:06:27
that peers are only qualified
00:06:29
15% of the time.
00:06:32
One of the reasons
00:06:33
the insurance companies
00:06:34
are able to behave this way
00:06:36
is because of market concentration.
00:06:38
73% of commercial markets, 71%
00:06:41
of Medicare Advantage
00:06:42
markets, and 90% of ACA
00:06:45
markets are considered
00:06:46
highly concentrated.
00:06:47
Some would argue this is a good thing,
00:06:50
because theoretically it would mean
00:06:51
that these insurance companies
00:06:53
can negotiate
00:06:53
better rates with hospitals,
00:06:55
and a smaller
00:06:56
number of payers
00:06:57
would lower administrative burden.
00:06:59
But in reality, this is just not true.
00:07:02
Multiple mergers
00:07:04
have been studied over the years,
00:07:05
including Aetna and Prudential,
00:07:07
UnitedHealth and Sierra and more.
00:07:09
When studied, the results are almost
00:07:11
always the same.
00:07:13
Premiums rise
00:07:14
as the market consolidates.
00:07:16
Instead of passing on savings
00:07:18
to customers,
00:07:19
insurers take advantage
00:07:20
of their market dominance
00:07:21
and increase prices and profits.
00:07:24
And this competitive positioning
00:07:25
is very hard to usurp.
00:07:28
The barrier
00:07:28
to entry of launching
00:07:29
a new paper
00:07:30
is very high due
00:07:31
to regulatory requirements.
00:07:33
Anti-competitive practices and scale.
00:07:36
These insurance companies
00:07:37
have gone a step further
00:07:39
and have begun to vertically integrate
00:07:41
in 2010.
00:07:42
The Affordable Care Act
00:07:43
effectively capped insurance
00:07:44
profit margins
00:07:46
by requiring
00:07:46
that insurers spend 80 to 85%
00:07:49
of what they collect
00:07:50
on medical services.
00:07:52
While this sounds nice in theory,
00:07:54
in practice
00:07:54
it led to insurance
00:07:56
companies seeking profits elsewhere.
00:07:58
For example, UnitedHealth directly
00:08:01
employs 10,000 physicians
00:08:03
and has commercial ties
00:08:05
to an additional 80,000, combined
00:08:08
that is 10% of all American doctors.
00:08:11
Again, this might sound nice,
00:08:13
but as you concentrate more power
00:08:15
into the hands of a few payers,
00:08:17
the ability to increase prices
00:08:19
and generate greater profits
00:08:21
also rises.
00:08:22
This again
00:08:23
is at odds
00:08:24
with the goal of achieving
00:08:25
better health outcomes.
00:08:27
The problem
00:08:27
with the current US health
00:08:28
care insurance regime is that success
00:08:31
for insurance
00:08:32
companies is not success
00:08:33
for the patients.
00:08:35
The unnecessary complexity
00:08:36
of the regime,
00:08:37
mixed with the consolidated power
00:08:39
of the major players, has failed
00:08:42
to lower costs
00:08:43
or improve patient outcomes.
00:08:45
Put simply, it is fundamentally broken.
00:08:51
We've
00:08:51
talked a lot about US
00:08:52
health insurance companies,
00:08:54
but they aren't
00:08:55
the only reason
00:08:56
the health care system is broken.
00:08:58
Health care
00:08:58
providers are also
00:08:59
a part of the problem.
00:09:01
Let's start off with doctors.
00:09:03
This might be hard
00:09:04
for some to believe,
00:09:05
but US doctors are a major contributor
00:09:08
to the overpriced healthcare system.
00:09:10
Take a look at this chart.
00:09:12
It shows the compensation for US
00:09:14
doctors compared
00:09:15
to doctors of other countries.
00:09:17
There are many reasons
00:09:18
why doctors in the US are paid more,
00:09:20
but one of the primary drivers
00:09:22
is the low supply of doctors.
00:09:24
The US has 2.6 practicing physicians
00:09:27
per 1000 people,
00:09:29
compared to the OECD average of 3.7.
00:09:32
But why are there so few doctors
00:09:34
in the US? Simple.
00:09:36
The American Medical Association
00:09:38
artificially constrained supply.
00:09:41
20 years ago,
00:09:42
the AMA
00:09:43
lobbied to reduce
00:09:44
the number of medical schools,
00:09:46
cap federal funding for residencies,
00:09:48
and cut a quarter
00:09:49
of all residency positions.
00:09:52
Because, I quote, they were worried
00:09:54
of an impending surplus of physicians.
00:09:57
This disgusting
00:09:59
move of regulatory capture,
00:10:00
influenced by greed,
00:10:02
meant
00:10:02
the number of medical school
00:10:03
graduates in 1980 was the same as 2005,
00:10:08
even though the US population
00:10:10
increased by 30%.
00:10:13
Now it isn't all the doctor's fault.
00:10:15
Hospital groups
00:10:16
and investors are also a big problem.
00:10:19
Similar to insurance, consolidation
00:10:21
in hospitals
00:10:22
and physician practices is very common.
00:10:25
One of the key drivers
00:10:26
for consolidation is the high
00:10:28
administrative burden
00:10:29
for physicians to remain independent.
00:10:31
Managing all the complexity
00:10:33
of a US
00:10:33
healthcare system
00:10:34
can not only be time consuming,
00:10:36
but costly. By joining larger groups
00:10:39
physicians are often able
00:10:40
to avoid dealing
00:10:41
with administrative headache
00:10:43
that comes with a smaller practice.
00:10:45
Over the past 20 years,
00:10:46
there have been 1000 mergers
00:10:48
among the country's
00:10:49
5000 hospitals,
00:10:51
and this extends beyond hospitals.
00:10:53
Today, three out of every four doctors
00:10:56
now works for a corporate group
00:10:57
or hospital.
00:10:59
Much of this has been executed
00:11:01
by private equity firms.
00:11:02
The one benefit of private equity
00:11:04
is that it
00:11:04
generally lowers costs
00:11:05
within practices,
00:11:07
which should, in theory,
00:11:08
lead to lower prices for patients.
00:11:10
However, given patients
00:11:12
are captive customers,
00:11:13
private equity groups
00:11:14
are fully incentivized
00:11:16
to increase prices.
00:11:17
It's the perfect investment.
00:11:20
Based on a recent study.
00:11:21
When PE firms control
00:11:22
more than 30% of a market.
00:11:24
Prices rise meaningfully.
00:11:26
Specifically, the study saw price
00:11:28
rises of 18%, 16%, and 13%
00:11:33
for Gastro
00:11:34
OBGYN and dermatological practices,
00:11:36
respectively.
00:11:37
One of the most egregious
00:11:39
examples of price rises
00:11:41
was US Anesthesia Partners.
00:11:43
After achieving
00:11:44
significant market
00:11:45
concentration in Denver.
00:11:47
USAP was noted as charging
00:11:49
reimbursement rates
00:11:50
30 to 40% higher than competing groups.
00:11:54
By acquiring a large
00:11:55
share of anesthesiologists
00:11:57
in the Denver area,
00:11:59
payers and patients
00:12:00
had little to no choice
00:12:02
but to pay whatever USAP asked.
00:12:05
All of this
00:12:06
while USAP lowered their own costs.
00:12:10
The saddest part?
00:12:11
Quality of care doesn't increase
00:12:14
and might actually decrease.
00:12:16
A University of Chicago study
00:12:18
found that PE ownership
00:12:20
of nursing homes led to a 10% rise
00:12:23
in short term mortality rates.
00:12:25
Another Harvard study
00:12:27
found that quality of care
00:12:28
declined once
00:12:30
a hospital was acquired by PE firms.
00:12:32
They noted a 25% increase
00:12:35
in hospital complications
00:12:36
and a 38% increase
00:12:38
in bloodstream infections.
00:12:40
Although this may seem
00:12:41
surprising to some,
00:12:42
it makes perfect sense.
00:12:44
To maximize profits,
00:12:46
the best course of action
00:12:47
is to increase the revenue
00:12:49
per patient, per doctor.
00:12:51
This operating leverage
00:12:52
will definitely increase margins,
00:12:54
but may compromise the quality of care.
00:12:57
And since most PE deals are financed
00:12:59
with large sums of debt,
00:13:01
investors are under pressure
00:13:02
to generate additional free cash flow
00:13:04
to pay down the debt.
00:13:06
This might mean cutting corners
00:13:08
to stay afloat,
00:13:09
but it isn't just private hospitals
00:13:11
or PE back rooms
00:13:12
that are part of the problem.
00:13:14
Even nonprofits
00:13:15
hospitals are exemplifying
00:13:17
extreme greed.
00:13:19
For example, the former CEO of UPMC,
00:13:22
a nonprofit hospital, made nearly
00:13:24
$13 million in fiscal year 2022.
00:13:29
Yes, the head of a nonprofit
00:13:31
hospital made nearly $13 million.
00:13:35
When asked about his compensation,
00:13:37
this is what he had to say.
00:13:38
Well, that's your judgment of it.
00:13:40
I think my board determines
00:13:43
what the appropriate
00:13:44
compensation is for me
00:13:45
and for all the other executives.
00:13:47
The conclusion for health care
00:13:48
providers, again, is simple
00:13:50
the pursuit of controlling supply
00:13:53
has led to the ability
00:13:54
to drive up price
00:13:55
without concerns for quality of care.
00:13:58
This applies to doctors
00:13:59
who have artificially lowered
00:14:01
their numbers, and clinic groups
00:14:02
who continue to consolidate
00:14:04
doctors and power.
00:14:08
The last element we
00:14:10
will explore is pharma.
00:14:11
The United States represents
00:14:13
approximately 44% of the world's
00:14:15
pharmaceutical market.
00:14:17
That's over
00:14:17
$600 billion on a per capita basis.
00:14:21
The US spends more on drugs
00:14:22
than anyone else, spending nearly 50%
00:14:25
more than the next highest
00:14:26
country, Germany.
00:14:28
But why? Is the US
00:14:29
just buying different,
00:14:30
better medicines?
00:14:32
No.
00:14:32
In fact,
00:14:33
they're buying
00:14:34
the exact same medicines.
00:14:36
But just paying a lot more.
00:14:39
When Bloomberg analyzed
00:14:40
eight of the best
00:14:41
selling drivers in the US,
00:14:42
even after applying discounts,
00:14:45
all but one or more expensive in the US
00:14:47
than any other major country,
00:14:50
and generally by a wide margin.
00:14:53
One of the more extreme
00:14:54
examples is for the chronic
00:14:56
myeloid leukemia pill Gleevec,
00:14:58
which costs $90,000 a year more
00:15:01
in the US
00:15:02
than the rest of the world, on average.
00:15:04
The craziest part about this, though?
00:15:06
The difference in
00:15:07
price is not just limited
00:15:08
to the US and other countries.
00:15:10
Even within states and counties,
00:15:12
people pay different prices.
00:15:15
Take a commonly used generic versions
00:15:17
of a prostate cancer treatment, Zytiga
00:15:20
they have more than 2200 prices
00:15:22
in Medicare plans.
00:15:24
For example, in Northern Michigan
00:15:26
you'll pay $815,
00:15:28
but hop around to Lake Michigan
00:15:31
and it jumps to nearly $3,400.
00:15:35
One of the reasons given
00:15:36
by pharmaceutical companies
00:15:37
as to the high price of drugs
00:15:39
is R&D costs.
00:15:40
R&D is often the largest expense
00:15:42
for pharma companies,
00:15:44
generally comprising
00:15:45
20 to 40% of revenues.
00:15:47
In addition,
00:15:48
the vast majority of all drug ideas
00:15:50
fail,
00:15:51
making the process
00:15:52
to identify and commercialize
00:15:53
a new drug
00:15:54
extremely time consuming and risky.
00:15:57
However, pharma
00:15:58
companies still generate
00:16:00
substantial margins
00:16:01
and returns on invested capital
00:16:03
as outside of R&D.
00:16:05
These pharma companies
00:16:06
are extremely capital efficient,
00:16:08
and clearly pharma companies
00:16:10
are charging less to other countries.
00:16:12
The main reason medicine in the US is
00:16:14
so expensive
00:16:15
is because,
00:16:16
unlike the rest of the developed world,
00:16:18
the US government does
00:16:19
not negotiate directly
00:16:21
with pharma companies.
00:16:22
In fact, they aren't even allowed to,
00:16:24
as per
00:16:25
the Medicare Noninterference clause,
00:16:28
by spreading the negotiating power
00:16:29
across payers.
00:16:31
The US is unable to realize the scale
00:16:33
benefits that it has.
00:16:35
This negotiating power
00:16:36
was further eroded
00:16:38
when the Medicaid drug
00:16:39
rebate program was put in place.
00:16:41
In essence, the program
00:16:42
set a maximum
00:16:43
price for drugs within Medicaid.
00:16:45
But in doing so,
00:16:46
pharma companies
00:16:47
made up for the lost
00:16:48
revenue with other payers.
00:16:50
The problem with pharma
00:16:52
is not only about prices,
00:16:53
but it's also about ethics.
00:16:55
In 2014,
00:16:56
the open Payments
00:16:57
Database was launched to disclose
00:16:59
financial relationships
00:17:01
between health care providers
00:17:02
and pharma companies.
00:17:04
Now, you might ask,
00:17:05
outside of employment,
00:17:06
why would pharma companies pay doctors?
00:17:09
Very simple.
00:17:10
Pharma companies
00:17:11
want people to use their medicines,
00:17:13
and the only thing in their way
00:17:15
is a doctor prescribing it.
00:17:17
To this end,
00:17:17
they offer illegal kickbacks
00:17:19
and other incentives
00:17:20
to ensure
00:17:21
that doctors recommend their drug
00:17:23
and not someone else's.
00:17:24
Sadly, this behavior is on the rise.
00:17:27
Since
00:17:27
2014, payments have grown from 6.5
00:17:30
billion to $12.8 billion.
00:17:34
Not all of this is illegal,
00:17:36
but in our view,
00:17:37
almost all of it is a gray area.
00:17:39
How can you be sure
00:17:40
that a doctor will be objective
00:17:42
if they have pharma companies
00:17:44
supporting their research,
00:17:45
giving them speaking fees,
00:17:47
hiring them as consultants?
00:17:48
And most atrocious
00:17:49
of all, paying them kickbacks.
00:17:52
There are dozens of examples
00:17:53
of bad behavior.
00:17:54
Novartis in 2010, Pfizer in 2014,
00:17:58
and then more recently, Purdue Pharma
00:18:00
with the opioid crisis.
00:18:02
This is not a financial crime.
00:18:04
Rather, it is a crime against humanity.
00:18:07
The pharma system is very, very broken.
00:18:10
Not only do Americans
00:18:11
pay exorbitant amounts
00:18:13
for the same drug,
00:18:14
but they can't even be sure
00:18:15
that they are being prescribed
00:18:16
the right medicines.
00:18:21
Now, that was a ton of information.
00:18:23
And frankly,
00:18:24
we cut out a lot,
00:18:25
including the impact of PBMs,
00:18:27
hidden fees, price transparency.
00:18:30
The problems with Medicare Advantage,
00:18:32
the destruction of rural hospitals,
00:18:34
and more.
00:18:35
Simply put,
00:18:36
the US health care
00:18:37
system is a behemoth,
00:18:38
and it is very complicated.
00:18:41
But from this complexity rises
00:18:43
extreme inefficiency
00:18:44
and the failure
00:18:45
to achieve the right health outcomes.
00:18:47
That said,
00:18:48
if you are wealthy
00:18:49
and financially stable,
00:18:51
the US health care system
00:18:52
is likely the best on Earth.
00:18:55
The US has the most advanced
00:18:56
technologies,
00:18:57
the most advanced facilities,
00:18:59
arguably the best doctors in the world.
00:19:02
The catch?
00:19:03
You must be able
00:19:04
and willing to pay for it.
00:19:06
The US health care
00:19:07
system is a Lamborghini.
00:19:09
Yes, it is capable, but at what cost?
00:19:12
Would we accept
00:19:13
a world
00:19:14
where the only car you can drive
00:19:16
was a luxury vehicle?
00:19:18
No.
00:19:19
Medicine is an enterprise.
00:19:20
Sure.
00:19:21
But it's different.
00:19:22
It's not about selling
00:19:24
the tastiest cheeseburger.
00:19:25
Nor is it about changing your car tire,
00:19:28
so you can get to work.
00:19:29
It is life or death.
00:19:31
It is as human as it gets.
00:19:33
And even if
00:19:34
you are opposed to a government run
00:19:36
health care model,
00:19:37
you have to admit that those models
00:19:40
are still better
00:19:41
than what the US has today.
00:19:43
Not only is the US
00:19:44
the most expensive in the world,
00:19:47
but it also has
00:19:48
some of the worst outcomes
00:19:50
in the developed world.
00:19:51
If you have watched our channel
00:19:52
for a while,
00:19:53
you might have ascertained
00:19:55
that we're not exactly socialist.
00:19:57
In fact,
00:19:58
you might argue
00:19:59
we are quite pro-business.
00:20:02
But don't let that fool you.
00:20:03
Above everything else,
00:20:04
we care about ethics and outcomes.
00:20:07
And to us, it doesn't matter
00:20:09
whether the US system is public
00:20:11
or private.
00:20:12
The fact of the matter is,
00:20:14
it is a disaster.
00:20:16
It is a system that would reject care
00:20:18
to a sick child
00:20:20
because of prior authorization.
00:20:22
It is a system
00:20:23
that would increase
00:20:24
emergency medicine fees
00:20:25
and surprise recovering patients
00:20:27
with an insurmountable bill.
00:20:29
It is a system where costs continue
00:20:32
to rise, outcomes continue to decline,
00:20:35
and nothing seems to improve.
00:20:37
So we must ask ourselves, is
00:20:39
greed always good?
00:20:42
Thank you for watching.
00:20:44
Subscribe to 2&20
00:20:45
for more on business, economics
00:20:48
and politics.